Orion Investor Relations Material
Latest events
CMD 2025
Orion
Access the full event backlog
Slides, Transcripts, and Reports from 13,000 public companies
Latest reports from Orion Oyj
Access all reports
Orion's Pharmaceuticals business area develops, produces and markets pharmaceuticals for various indications; provides specialized dietary products and enteral feeds for the needs of healthcare, including clinical nutrition services; manufactures APIs; and offers contract manufacturing, research and development (R&D), technical development services in the field of chemistry and biochemistry, as well as develops and commercializes patient monitoring and self-monitoring products. Orion Oyj was founded in 1917 and is headquartered in Espoo, Finland.
Key slides for Orion Oyj
Investor Presentation
Orion Oyj
CMD 2025
Orion Oyj
Latest articles
)
David A. Ricks: Eli Lilly's Chairman and CEO
David Ricks built a decades-long career at Eli Lilly, now leading the giant company through a defining moment in its long pharmaceutical history.
3 Jul 2025
)
D. E. Shaw & Co: Inside the Quiet Giant of Quant Finance
A deep dive into D. E. Shaw's evolution from a $28M quant startup to a $65B hedge fund giant, built on research, computing, and quiet consistency.
2 Jul 2025
)
Pershing Square Capital Management: Conviction, Reinvention, and Contrarian Investing
Pershing Square Capital Management has grown into a top-tier hedge fund through reinvention, conviction, and focus on long-term value creation.
2 Jul 2025
Ticker symbol
ORNBV
Country
🇫🇮 Finland